Application note: Integrated biologics – Enabling high-throughput drug discovery at Amgen with Thermo Fisher™ Platform for Science™ Software
Posted: 29 November 2018 | Thermo Fisher Scientfic | No comments yet
Every day scientists are working to discover and develop new therapies and treatments to change the lives of patients suffering from serious and debilitating illnesses. Amgen Inc. has made it a priority to unlock the potential of biology to discover, develop, manufacture, and deliver innovative therapeutics to patients.
Please complete the form below in order to download this application note:
Related content from this organisation
- CRISPR-Cas9-based gene dropout screens: a powerful platform for drug discovery
- The diversity of synthetic biology applications
- Under the microscope: Leveraging CRISPR libraries for target discovery
- Application note: Improving and simplifying the design of knock-in experiments using the TrueDesign Genome Editor
- Better therapeutic antibodies by design
Related topics
Bioinformatics, Biologics, Biopharmaceuticals, Disease research, DNA, Drug Discovery, Drug Discovery Processes, Informatics, Research & Development, Therapeutics
Related organisations
Amgen, Thermo Fisher Scientific
